Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.89x is 43% above its 5-year average of 1.32x, near the high end of its 5-year range (-19.91x–2.88x).
20.04% below its 12-month average of 2.36x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-07-04): 2.88x.
INTEREST COVERAGE RATIO
1.89x
INTEREST COVERAGE RATIO AVG TTM
2.36x
INTEREST COVERAGE RATIO AVG 3Y
1.58x
INTEREST COVERAGE RATIO AVG 5Y
1.32x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.04%
CURRENT VS 3Y AVG
+19.32%
CURRENT VS 5Y AVG
+43.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-3.05x
median of 295 covered companies
CURRENT VS SECTOR MEDIAN
+161.97%
vs the sector median at left
Aveanna Healthcare Holdings Inc.
Market Cap
$2.69B
Interest Coverage Ratio
1.89x
TTM Avg
2.36x
3Y Avg
1.58x
5Y Avg
1.32x
Market Cap
$2.69B
Interest Coverage Ratio
2.79x
TTM Avg
3.64x
3Y Avg
5.04x
5Y Avg
5.11x
Market Cap
$2.64B
Interest Coverage Ratio
-78.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.64B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.87B
Interest Coverage Ratio
-0.59x
TTM Avg
11.23x
3Y Avg
11.23x
5Y Avg
11.23x
Market Cap
$2.87B
Interest Coverage Ratio
7.88x
TTM Avg
5.24x
3Y Avg
5.24x
5Y Avg
5.24x
Market Cap
$2.51B
Interest Coverage Ratio
-358.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.88B
Interest Coverage Ratio
-75.61x
TTM Avg
0.12x
3Y Avg
0.12x
5Y Avg
0.12x
Market Cap
$2.43B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.69B | 1.89x | 2.36x | 1.58x | 1.32x |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 2.79x | 3.64x | 5.04x | 5.11x |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | -78.14x | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -8.77x | N/A | N/A | N/A |
| AtriCure, Inc. (ATRC)vs › | $2.87B | -0.59x | 11.23x | 11.23x | 11.23x |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 7.88x | 5.24x | 5.24x | 5.24x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -358.08x | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | -75.61x | 0.12x | 0.12x | 0.12x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 26.93x | 18.45x | 12.59x | 12.59x |
Interest Coverage
1.9x
Debt/Equity
5.24
Current Ratio
1.16
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-07-04 | 2.88x |
| 2026-04-04 | 2.60x |
| 2026-01-03 | 2.37x |
| 2025-09-27 | 1.60x |
| 2025-06-28 | 2.22x |
| 2025-03-29 | 1.43x |
| 2024-12-28 | 1.20x |
| 2024-09-28 | 0.87x |
| 2024-06-29 | 0.94x |
| 2024-03-30 | 0.58x |
| 2023-12-30 | 0.74x |
| 2023-09-30 | -1.93x |
| 2023-07-01 | 0.99x |
| 2023-04-01 | 0.41x |
| 2022-12-31 | -6.02x |
| 2022-10-01 | 0.17x |
| 2022-07-02 | -19.91x |
| 2022-04-02 | 0.62x |
| 2022-01-01 | -7.47x |
| 2021-10-02 | 1.52x |
| 2021-07-03 | 1.57x |
| 2021-04-03 | 1.26x |
| 2020-12-31 | 0.74x |
| 2020-09-30 | 0.68x |
| 2020-06-30 | -2.76x |
| 2020-03-31 | 0.85x |
